Shangya Technology Past Earnings Performance
Past criteria checks 0/6
Shangya Technology's earnings have been declining at an average annual rate of -25.5%, while the Healthcare industry saw earnings growing at 7.1% annually. Revenues have been growing at an average rate of 21% per year.
Key information
-25.5%
Earnings growth rate
-14.2%
EPS growth rate
| Healthcare Industry Growth | 9.1% |
| Revenue growth rate | 21.0% |
| Return on equity | -20.9% |
| Net Margin | -55.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Shangya Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 206 | -114 | 80 | 0 |
| 30 Jun 24 | 211 | -110 | 78 | 0 |
| 31 Mar 24 | 215 | -76 | 85 | 0 |
| 31 Dec 23 | 231 | -80 | 84 | 0 |
| 30 Sep 23 | 196 | 54 | 81 | 0 |
| 30 Jun 23 | 164 | 55 | 79 | 0 |
| 31 Mar 23 | 121 | 5 | 70 | 0 |
| 31 Dec 22 | 85 | 1 | 65 | 0 |
| 30 Sep 22 | 90 | -10 | 68 | 0 |
| 30 Jun 22 | 85 | -2 | 61 | 0 |
| 31 Mar 22 | 99 | 24 | 65 | 0 |
| 31 Dec 21 | 104 | 32 | 70 | 0 |
| 30 Sep 21 | 118 | 10 | 81 | 0 |
| 30 Jun 21 | 133 | -8 | 106 | 0 |
| 31 Mar 21 | 134 | -28 | 118 | 0 |
| 31 Dec 20 | 138 | -27 | 117 | 0 |
| 30 Sep 20 | 126 | -20 | 103 | 0 |
| 30 Jun 20 | 98 | -17 | 77 | 0 |
| 31 Mar 20 | 71 | -15 | 54 | 0 |
| 31 Dec 19 | 63 | -16 | 45 | 0 |
| 30 Sep 19 | 49 | -27 | 41 | 0 |
| 30 Jun 19 | 50 | -29 | 38 | 0 |
| 31 Mar 19 | 53 | -27 | 36 | 0 |
| 31 Dec 18 | 54 | -23 | 35 | 0 |
| 30 Sep 18 | 63 | -12 | 29 | 0 |
| 30 Jun 18 | 71 | -12 | 28 | 0 |
| 31 Mar 18 | 80 | -11 | 27 | 0 |
| 31 Dec 17 | 86 | -10 | 28 | 0 |
| 30 Sep 17 | 104 | -3 | 31 | 0 |
| 30 Jun 17 | 121 | 2 | 33 | 0 |
| 31 Mar 17 | 148 | -1 | 39 | 0 |
| 31 Dec 16 | 179 | 2 | 46 | 0 |
| 30 Sep 16 | 200 | -2 | 55 | 0 |
| 30 Jun 16 | 222 | -9 | 64 | 0 |
| 31 Mar 16 | 235 | -4 | 69 | 0 |
| 31 Dec 15 | 245 | -3 | 71 | 0 |
| 30 Sep 15 | 259 | -8 | 73 | 0 |
| 30 Jun 15 | 275 | -3 | 75 | 0 |
| 31 Mar 15 | 283 | -10 | 76 | 0 |
| 31 Dec 14 | 300 | 21 | 86 | 0 |
| 30 Sep 14 | 346 | 13 | 99 | 0 |
| 30 Jun 14 | 515 | -18 | 162 | 0 |
| 31 Mar 14 | 771 | 21 | 227 | 0 |
| 31 Dec 13 | 786 | -6 | 229 | 0 |
Quality Earnings: 6130 is currently unprofitable.
Growing Profit Margin: 6130 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6130 is unprofitable, and losses have increased over the past 5 years at a rate of 25.5% per year.
Accelerating Growth: Unable to compare 6130's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6130 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6.3%).
Return on Equity
High ROE: 6130 has a negative Return on Equity (-20.94%), as it is currently unprofitable.